Eli Lilly And Company

This early-stage study tests a new drug called LY4152199 for adults with B-cell lymphoma that has come back or not responded to prior treatments. The drug is designed to help the body's immune cells attack cancer cells. The main goals are to find the safest dose and see if the dr…

This early-stage study tests a new drug called LY4584180 in adults with certain blood cancers (like lymphoma) that have not improved after at least two prior treatments. The main goals are to check the drug's safety, how the body processes it, and whether it can shrink tumors. Ab…

This study tests a new drug called LY4005130 for adults with non-segmental vitiligo, a condition that causes white patches on the skin. About 60 people will get either the drug or a placebo through an IV to see if it safely reduces the patches. The study lasts about 48 weeks and …

This study tests an experimental drug called brenipatide for adults with irritable bowel syndrome with diarrhea (IBS-D). About 531 participants will receive either the drug or a placebo as a shot under the skin. The goal is to see if it safely reduces daily abdominal pain and imp…

This study aims to see if a wearable headband that tracks brain waves at home can give the same sleep information as a full sleep lab test in people with early or no symptoms of Alzheimer's. About 35 participants will wear both devices at the same time in a lab for two nights, th…